z-logo
open-access-imgOpen Access
Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Author(s) -
Sonya Naryshkin,
R. Marshall Austin
Publication year - 2012
Publication title -
drug, healthcare and patient safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 24
ISSN - 1179-1365
DOI - 10.2147/dhps.s37273
Subject(s) - human papillomavirus , cervical cancer , medicine , cervical cancer screening , gynecology , oncology , risk analysis (engineering) , cancer
To increase awareness of the limitations of high-risk human papillomavirus (hrHPV) laboratory-developed testing (LDT) widely used in US cervical cancer screening.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here